XRAY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XRAY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Dentsply Sirona's quarterly accounts payable & accrued expense declined from Mar. 2024 ($987 Mil) to Jun. 2024 ($961 Mil) but then increased from Jun. 2024 ($961 Mil) to Sep. 2024 ($1,120 Mil).
Dentsply Sirona's annual accounts payable & accrued expense declined from Dec. 2021 ($749 Mil) to Dec. 2022 ($732 Mil) but then increased from Dec. 2022 ($732 Mil) to Dec. 2023 ($787 Mil).
The historical data trend for Dentsply Sirona's Accounts Payable & Accrued Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accounts Payable & Accrued Expense | Get a 7-Day Free Trial | 792.00 | 806.00 | 749.00 | 732.00 | 787.00 |
Dentsply Sirona Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Accounts Payable & Accrued Expense | Get a 7-Day Free Trial | 1,031.00 | 787.00 | 987.00 | 961.00 | 1,120.00 |
Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
Gregory T Lucier | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Simon D Campion | director, officer: President, CEO & Member of BOD | DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Glenn Coleman | officer: Executive VP & CFO | C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Andrea L. Frohning | officer: SVP, CHRO | C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Jonathan Jay Mazelsky | director | ONE IDEXX DRIVE, WESTBROOK ME 04092 |
Eric Brandt | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Staehler Cord Friedrich | officer: SVP, Chief Technology Officer | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Richard C Rosenzweig | officer: SVP, Corp Dev, GC & Secretary | C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Robert Anthony Johnson | officer: SVP, Chief Supply Chain Office | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Richard M Wagner | officer: VP, Chief Accounting Officer | 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991 |
Barbara W. Bodem | officer: Interim CFO | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Willem T Appelo | officer: SVP Chief Supply Chain Officer | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Andreas G Frank | officer: Executive VP, Product Group | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
John P Groetelaars | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Cheree H Johnson | officer: SVP,Chief Legal Ofcr, GC &Sec | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
From GuruFocus
By Marketwired • 11-29-2024
By GuruFocus News • 12-03-2024
By Business Wire • 12-03-2024
By Marketwired • 11-27-2024
By PRNewswire • 11-28-2024
By Marketwired • 12-03-2024
By Marketwired • 11-30-2024
By Marketwired • 12-06-2024
By Marketwired • 11-27-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.